Akari Therapeutics, Plc
AKTX
$0.92
-$0.005-0.54%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 5.00% | -0.65% | 15.72% | -46.23% | 218.85% |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | -28.71% | 581.52% | -76.77% | -50.81% | -34.55% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 2.14% | -46.36% | 183.70% | -2.13% | -59.48% |
Total Current Assets | -1.43% | 13.45% | 7.97% | -46.14% | 83.12% |
|
|||||
Total Current Assets | -1.43% | 13.45% | 7.97% | -46.14% | 83.12% |
Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
Long-term Investments | 0.00% | 0.00% | -- | -- | -- |
Goodwill | 0.00% | 0.00% | -- | -- | -- |
Total Other Intangibles | 0.00% | 0.00% | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | -- | -- |
Total Assets | -0.09% | 0.79% | 1,749.38% | -46.14% | 83.12% |
|
|||||
Total Accounts Payable | -11.17% | 5.32% | 159.45% | 2.05% | 46.07% |
Total Accrued Expenses | -29.36% | 11.38% | 20.42% | 54.60% | 10.13% |
Short-term Debt | -16.20% | -43.37% | 226.00% | 0.00% | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Liabilities | -39.36% | 126.04% | 6.24% | -26.07% | -11.28% |
Total Other Current Liabilities | -39.36% | 126.04% | 6.24% | -26.07% | -11.28% |
Total Current Liabilities | -18.03% | 5.01% | 111.18% | 7.39% | 38.80% |
|
|||||
Total Current Liabilities | -18.03% | 5.01% | 111.18% | 7.39% | 38.80% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -16.20% | -43.37% | 226.00% | 0.00% | -- |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -1.66% | -1.39% | -- | -- | -- |
Total Liabilities | -13.37% | 3.11% | 200.52% | 7.39% | 38.80% |
|
|||||
Common Stock & APIC | 2.75% | 1.49% | 17.52% | 0.04% | 4.15% |
Retained Earnings | -0.76% | -1.50% | -1.55% | -1.20% | -3.24% |
Treasury Stock & Other | -0.65% | -0.07% | 0.37% | -0.34% | 0.02% |
Total Common Equity | 17.75% | -2.17% | 432.07% | -80.77% | -4.22% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 17.75% | -2.17% | 432.07% | -80.77% | -4.22% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 17.75% | -2.17% | 432.07% | -80.77% | -4.22% |
|